<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Lyu S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Parkinson's disease (PD) is a progressive neurodegenerative condition. Chinese medicine therapies have demonstrated effectiveness for PD in controlled settings. However, the utilization of Chinese medicine therapies for PD in real-world clinical practice and the characteristics of patients seeking these therapies have not been thoroughly summarized.&lt;h4>Method&lt;/h4>The study retrospectively analyzed initial patient encounters (PEs) with a first-listed diagnosis of PD, based on electronic medical records from Guangdong Provincial Hospital of Chinese Medicine between July 2018 and July 2023.&lt;h4>Results&lt;/h4>A total of 3,206 PEs, each corresponding to an individual patient, were eligible for analyses. Approximately 60% of patients made initial visits to the Chinese medicine ho</pubmed_abstract><journal>Frontiers in aging neuroscience</journal><pagination>1362948</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11096516</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Real-world Chinese herbal medicine for Parkinson's disease: a hospital-based retrospective analysis of electronic medical records.</pubmed_title><pmcid>PMC11096516</pmcid><pubmed_authors>Zhang CS</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Su Q</pubmed_authors><pubmed_authors>Guo X</pubmed_authors><pubmed_authors>Luo X</pubmed_authors><pubmed_authors>Lyu S</pubmed_authors><pubmed_authors>Sun J</pubmed_authors><pubmed_authors>Mao Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Real-world Chinese herbal medicine for Parkinson's disease: a hospital-based retrospective analysis of electronic medical records.</name><description>&lt;h4>Background&lt;/h4>Parkinson's disease (PD) is a progressive neurodegenerative condition. Chinese medicine therapies have demonstrated effectiveness for PD in controlled settings. However, the utilization of Chinese medicine therapies for PD in real-world clinical practice and the characteristics of patients seeking these therapies have not been thoroughly summarized.&lt;h4>Method&lt;/h4>The study retrospectively analyzed initial patient encounters (PEs) with a first-listed diagnosis of PD, based on electronic medical records from Guangdong Provincial Hospital of Chinese Medicine between July 2018 and July 2023.&lt;h4>Results&lt;/h4>A total of 3,206 PEs, each corresponding to an individual patient, were eligible for analyses. Approximately 60% of patients made initial visits to the Chinese medicine ho</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-04-12T15:31:13.773Z</modification><creation>2026-04-07T13:17:43.071Z</creation></dates><accession>S-EPMC11096516</accession><cross_references><pubmed>38756536</pubmed><doi>10.3389/fnagi.2024.1362948</doi></cross_references></HashMap>